Search for: "Pfizer Corporation" Results 541 - 560 of 820
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2010, 10:12 am by Joe Consumer
Is it too much of a stretch to say that corporations want to own everything? [read post]
29 Mar 2010, 9:08 am by PRATER, DUNCAN & CRAIG 770-253-7778
Big Corporations not acting right, happens all the time: Pfizer Hit With $141 Million RICO Penalty Over Neurontin Promotion: Link To ArticlePRATER,DUNCAN&CRAIG: 770-253-7778: Trial Lawyers For Justice [read post]
23 Mar 2010, 10:00 pm by Jim Hassett
  This pressure started long before the Great Recession, with companies like Dupont, Cisco, FMC Technologies, and Pfizer in the lead. [read post]
Approximately 60 non-TARP companies, including Microsoft, Pfizer and Verizon, have either put, or announced plans to put, management say on pay proposals on their ballots. [read post]
17 Mar 2010, 5:52 am by Kelly
Other companies include Pfizer, Dell and Wyeth. [read post]
16 Mar 2010, 7:50 am by Dennis Crouch
[Link] Corporate IP Counsel Summit (April 27-28) in New York. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
8 Mar 2010, 7:49 am by Broc Romanek
Supermajority Provisions As of Feb. 15, investors had filed 26 proposals that seek to repeal supermajority requirements to approve bylaws, corporate transactions, and other matters. [read post]
8 Mar 2010, 12:48 am by John J. Cord
FDA: The FDA is going to step up criminal prosecutions of corporate officials. [read post]
2 Mar 2010, 6:28 am by John J. Cord
But, comments have been received at the 11th hour by the following companies: AstraZeneca, Pfizer, Merck, Lilly, Medtronic, Novartis and Abbott. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
24 Feb 2010, 5:00 am by Doug Cornelius
This roundtable discussion comprised…Read more » Working Toward a Healthier Organization: Pfizer’s Compliance Program There are a number of challenges associated with maintaining integrity as a top priority in a highly competitive global business. [read post]
23 Feb 2010, 1:17 pm by Ilya Somin
In November, the Pfizer Corporation, whose lobbying helped instigate the initial takings, announced the planned closing of its headquarters in New London. [read post]
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/14: Daiichi Sankyo Inc.and Genzyme Corporation v. [read post]
3 Feb 2010, 9:39 pm by Andrew Russell
In this particular case Pfizer, a Delaware corporation with its principal place of business in New York, brought an ANDA suit against Sandoz, Inc., a Colorado corporation with its principal place of business in New Jersey, but also with its primary manufacturing plant located in Colorado. [read post]